ADIPOGEN CORPORATION

ADIPOGEN CORPORATION specializes in the manufacturing and supply of high-purity organic chemical compounds and biological materials for federal research and healthcare applications. Their technical expertise lies in the synthesis, purification, and quality-controlled production of complex organic molecules used in biomedical research, diagnostics, and therapeutic development. The company demonstrates precision in handling sensitive chemical intermediates and biological reagents, ensuring compliance with stringent purity and stability standards required for federal laboratory and clinical use. Their differentiation stems from a focused capability in producing specialized chemical materials under controlled manufacturing conditions, supporting mission-critical applications in life sciences and public health. The contractor has delivered products directly to the Department of Health and Human Services, supplying essential biological materials and chemical reagents likely used in research, testing, or regulatory functions within agencies such as NIH or CDC. This relationship suggests a trusted vendor status for niche, non-commercial-grade chemical substances that support federal scientific initiatives, with work focused on supply chain reliability and material integrity rather than large-scale production. ADIPOGEN’s primary NAICS classification, 325199, reflects its role in manufacturing specialty organic chemicals not covered by broader categories—such as custom-synthesized intermediates, reference standards, or research-grade compounds. This positions the company within the niche segment of the chemical manufacturing industry that serves government and academic research environments requiring bespoke or low-volume, high-purity materials. Their market positioning is that of a specialized supplier rather than a bulk manufacturer. As a 2L entity based in San Diego, California, ADIPOGEN CORPORATION operates as a small-scale, technically focused manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic presence aligns with the biotech and pharmaceutical corridor of Southern California, enabling proximity to research institutions and federal labs. The company’s business model centers on precision chemical production for mission-driven federal science programs.